Zaccarini François, Falconer Henrik
Department of Pelvic Cancer, Karolinska University Hospital and the Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Curr Opin Oncol. 2025 Sep 1;37(5):464-469. doi: 10.1097/CCO.0000000000001156. Epub 2025 May 14.
Endometrial cancer is the most common gynecological cancer among women in high-income countries and the prevalence is projected to increase worldwide because of the obesity epidemic. Surgery is a key step in the management of endometrial cancer. Performing surgery and delivering care to obese patients (BMI ≥ 30 kg/m 2 ) and especially to morbidly obese patients (BMI ≥ 40 kg/m 2 ) is challenging.This review focuses on the advantages of robotic surgery in obese patients with endometrial cancer.
The emergence of robotic surgery is associated with increasing rates of minimally invasive surgery for endometrial cancer. Robotic surgery offers several advantages over conventional laparoscopy, especially in obese patients with endometrial cancer which has led to decreasing rates of conversion to laparotomy. The approach allows surgical staging on obese and morbidly obese patients without increasing complication rates or the length of hospital stay, while improving ergonomics for the surgeon.
Robotic surgery should be the preferred approach for obese patients with endometrial cancer. Current data confirm its safety and benefits for this group of women, particularly for obese patients with a BMI ≥ 40 kg/m 2 .
子宫内膜癌是高收入国家女性中最常见的妇科癌症，由于肥胖流行，预计其在全球的患病率将会上升。手术是子宫内膜癌治疗的关键步骤。对肥胖患者（BMI≥30kg/m²）尤其是病态肥胖患者（BMI≥40kg/m²）进行手术和提供护理具有挑战性。本综述重点关注机器人手术在肥胖子宫内膜癌患者中的优势。
机器人手术的出现与子宫内膜癌微创手术率的增加相关。与传统腹腔镜手术相比，机器人手术具有若干优势，特别是在肥胖子宫内膜癌患者中，这导致开腹手术转化率降低。该方法能够对肥胖和病态肥胖患者进行手术分期，而不增加并发症发生率或住院时间，同时改善了外科医生的操作舒适度。
机器人手术应成为肥胖子宫内膜癌患者的首选治疗方法。目前的数据证实了其对这组女性的安全性和益处，特别是对于BMI≥40kg/m²的肥胖患者。
